# Livzon Group (Ningxia) Pharmaceutical Co., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/livzon-group-ningxia-pharmaceutical-co-ltd/78a1f9d4-41d0-440a-87bc-8c9521d0159a

> Inspection records and compliance data for Livzon Group (Ningxia) Pharmaceutical Co., Ltd. in Shizuishan, None. Access full analysis and detailed observations.

---

## Details

- Name: Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
- FEI Number: 3012375554
- City: Shizuishan
- State: None
- Country Name: China
- Address Line 1: Pingluo Industrial Park, Toushi Road West,301 Provincial Highway South
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1286526 - Livzon Group (Ningxia) Pharmaceutical Co., Ltd. - 2025-09-05](https://www.keypedia.com/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/17259637-8bb1-4159-a363-354a53004e96) — source: FDA, date: September 5, 2025
- [FDA Inspection 1286526 - Livzon Group (Ningxia) Pharmaceutical Co., Ltd. - 2025-09-05](https://www.keypedia.com/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/669253d4-be4d-43db-a8ca-3debe6b81bf4) — source: FDA, date: September 5, 2025
- [FDA Inspection 1286526 - Livzon Group (Ningxia) Pharmaceutical Co., Ltd. - 2025-09-05](https://www.keypedia.com/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/3807d04f-359d-4381-adeb-4bb36afcc7bc) — classification: No Action Indicated (NAI), source: FDA, date: September 5, 2025
- [FDA Inspection 1286526 - Livzon Group (Ningxia) Pharmaceutical Co., Ltd. - 2025-09-05](https://www.keypedia.com/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/851f62b2-0417-46fb-a423-77ac6fae1dd7) — classification: No Action Indicated (NAI), source: FDA, date: September 5, 2025
- [483 - Livzon Group (Ningxia) Pharmaceutical Co., Ltd. - 2019-12-06](https://www.keypedia.com/records/483/livzon-group-ningxia-pharmaceutical-co-ltd/9bfeb219-f90b-492a-9ffd-2097dfac7b48) — source: FDA, date: December 6, 2019
- [FDA Inspection 1115730 - Livzon Group (Ningxia) Pharmaceutical Co., Ltd. - 2019-12-06](https://www.keypedia.com/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/a0f62698-dff7-47a7-8640-a8960fab5408) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2019
- [483 - Livzon Group (Ningxia) Pharmaceutical Co., Ltd. - 2018-10-19](https://www.keypedia.com/records/483/livzon-group-ningxia-pharmaceutical-co-ltd/ca2b5e84-c11a-4060-af74-e395a6c584ed) — source: FDA, date: October 19, 2018
- [FDA Inspection 1070291 - Livzon Group (Ningxia) Pharmaceutical Co., Ltd. - 2018-10-19](https://www.keypedia.com/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/a82b46fe-c65c-416b-a72d-567fb166f2f3) — classification: Official Action Indicated (OAI), source: FDA, date: October 19, 2018
- [FDA Inspection 1070291 - Livzon Group (Ningxia) Pharmaceutical Co., Ltd. - 2018-10-19](https://www.keypedia.com/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/512d3381-c046-424e-a3b3-8219f6e7698b) — classification: Official Action Indicated (OAI), source: FDA, date: October 19, 2018
- [FDA Inspection 998978 - Livzon Group (Ningxia) Pharmaceutical Co., Ltd. - 2017-01-13](https://www.keypedia.com/records/fda_inspections/livzon-group-ningxia-pharmaceutical-co-ltd/b3c7fe6a-532f-4d1a-9777-125f9bdba24d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 13, 2017

## Related Companies

- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/3a9656ad-737b-4682-9ab3-951b1041002e)
- [Navinta, LLC](https://www.keypedia.com/companies/navinta-llc/2049d986-174a-414f-812b-0f4347426e48)
- [Solara Active Pharma Sciences Limited](https://www.keypedia.com/companies/solara-active-pharma-sciences-limited/acf65b82-5b4f-4ec5-b3c0-56f3eaed2657)
- [Bachem AG](https://www.keypedia.com/companies/bachem-ag/993b3279-f93a-4e57-ae71-897be8bf52fd)
- [Carbogen Amcis AG](https://www.keypedia.com/companies/carbogen-amcis-ag/037a800d-23cd-48db-8f38-88cde58f6da4)
- [Nantong Chanyoo Pharmatech Co., Ltd.](https://www.keypedia.com/companies/nantong-chanyoo-pharmatech-co-ltd/ccfeb4b8-1b9a-4c2c-a01f-f1afcf289155)
- [Heraeus Deutschland GmbH & Co. KG](https://www.keypedia.com/companies/heraeus-deutschland-gmbh-co-kg/708b05d7-c6ee-4a2d-a083-a225f5ad8871)
- [Sun Pharmaceutical Industries Limited- Madhuranthagam](https://www.keypedia.com/companies/sun-pharmaceutical-industries-limited-madhuranthagam/29c2adf0-d756-44f5-aefc-28f06be9616a)
- [MRIGlobal](https://www.keypedia.com/companies/mriglobal/52b432ff-e4bd-4ce2-80b5-30d4f35e5015)
- [DSM Nutritional Products France SAS](https://www.keypedia.com/companies/dsm-nutritional-products-france-sas/eded103b-8b4a-4634-a232-fb06e26f585d)

## Related Officers

- [Joel D. Hustedt](https://www.keypedia.com/people/joel-d-hustedt/29440042-08dd-4dce-be48-b55f8e1d7080)
- [Vincent Thomas](https://www.keypedia.com/people/vincent-thomas/0925480c-5d8c-411f-86ee-5e4b924f8c12)
- [Jose M. Cayuela](https://www.keypedia.com/people/jose-m-cayuela/3ee89bb5-4bba-493b-816f-31b8a9768025)